Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Linkedin

  1. Home
  2. Community Center
  3. Social Media
  4. Linkedin
Alnylam Rare Disease
Alnylam Pharmaceuticals - Linkedin
Read more
Association of Black Cardiologists, Inc. - LinkedIn
Read more
Pfizer - Linkedin
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and…
Read more
Eidos Therapeutics - Linkedin
Read more
Nephros, Inc. - Linkedin
Read more
BSIM Therapeutics - Linkedin
Read more
SOM Biotech - Linkedin
Read more
Prothena Corporation PLC - Linkedin
Read more
Ionis Pharmaceuticals, Inc. - Linkedin
Read more
Amyloidosis Foundation - LinkedIn
Read more
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on